Propane (entering from the left) can form propylene—an important polymer building block—and hydrogen (exiting to the right) over a titanium oxide catalyst (red and white spheres) coating an underlying nickel nanoparticle (blue) supported on aluminum oxide (gray). The oxygen-deficient titanium dioxide overlayers become much more active for forming propylene because nickel helps activate carbon-hydrogen bond breaking and hydrogen desorption. Learn more this week in Science: https://scim.ag/7Is
Science Magazine
Book and Periodical Publishing
Washington, DC 328,697 followers
The world's leading outlet for scientific news, commentary, and cutting-edge research.
About us
Founded in 1880 on $10,000 of seed money from the American inventor Thomas Edison, Science has grown to become the world's leading outlet for scientific news, commentary, and cutting-edge research, with the largest paid circulation of any peer-reviewed general-science journal. Through its print and online incarnations, Science reaches an estimated worldwide readership of more than one million. In content, too, the journal is truly international in scope; some 35 to 40 percent of the corresponding authors on its papers are based outside the United States. Its articles consistently rank among world's most cited research.
- Website
-
http://www.science.org
External link for Science Magazine
- Industry
- Book and Periodical Publishing
- Company size
- 51-200 employees
- Headquarters
- Washington, DC
- Type
- Nonprofit
Locations
-
Primary
1200 New York Avenue NW
Washington, DC 20005, US
Employees at Science Magazine
Updates
-
Researchers have developed Click3D, a method for thoroughly staining whole organs using click chemistry. Learn more in this week’s issue of #ScienceAdvances: https://scim.ag/7Ju
-
-
Science Magazine reposted this
NASA's VIPER rover was basically ready to go. So why did the agency kill it? The answer, evidence that X is hiding purchased votes in its polls, and more of the best from Science Magazine and science in this edition of #ScienceAdviser: https://lnkd.in/gVQh8zgu
-
-
Science Magazine reposted this
On our 19 July 2024 cover of Science Magazine, Chris Bickel takes us nanoscale to illustrate a cheaper way to produce plastics using nickel vs. platinum.
Propane (entering from the left) can form propylene—an important polymer building block—and hydrogen (exiting to the right) over a titanium oxide catalyst (red and white spheres) coating an underlying nickel nanoparticle (blue) supported on aluminum oxide (gray). The oxygen-deficient titanium dioxide overlayers become much more active for forming propylene because nickel helps activate carbon-hydrogen bond breaking and hydrogen desorption. Learn more this week in Science: https://scim.ag/7Is
-
-
Insecticides made of RNA could offer a safer and more targeted weapon against crop pests. Learn more in this #NewsfromScience feature: https://scim.ag/7Jb
-
-
The major human bacterial pathogen Pseudomonas aeruginosa causes multidrug-resistant infections, particularly in people with underlying immunodeficiencies or inflammatory lung diseases such as cystic fibrosis. A new Science study describes the key sequential steps involved in the evolution of Pseudomonas aeruginosa from an environmental organism to a major human pathogen. https://scim.ag/7IV
-
-
Bacterial infections, #SARSCoV2, and #Alzheimers proteins can activate a brain-muscle axis linking neuroinflammation to muscle dysfunction, according to a new #ScienceImmunology study in mice and flies. Read more: https://scim.ag/7ID
-
-
Science Magazine reposted this
This visualization of the lingering effects of "magic" mushrooms is real trippy. That story and more of the best in Science Magazine and science in this edition of #ScienceAdviser: https://lnkd.in/gxYThJY5
-
-
Science Magazine reposted this
New Perspective from Daniel Drucker in Science Magazine explores the potential of GLP-1 innovation to improve health outcomes in people with a range of chronic disorders. "A wide range of clinical trials is underway, with results likely to support expansion of the range of clinical indications benefiting from GLP-1 therapies. Hence, after almost two decades of the clinical use of GLP-1 for T2D and 10 years after the first GLP-1 medicine, liraglutide, was approved for weight loss in people with obesity, the next decade may bring even greater progress, introducing more powerful GLP-1 medicines while expanding the utility of GLP-1 therapeutics beyond currently established cardiometabolic disorders." https://lnkd.in/e8Pudb52
-
A 2023 #ScienceImmunology Review suggests combining inhibitory strategies, such as ICI, alongside radiotherapy may counteract the creation of immunosuppressive adenosine during cancer immunotherapy. Learn more: https://scim.ag/7Ib #ScienceMagArchives
-